Project Scope

To analyze the acute and episodic migraine markets in Egypt and Saudi Arabia, focusing on access, pricing, and reimbursement mechanisms, to determine the potential for an upcoming therapy

Challenge

The client aimed to gather insights on the affordability landscape, solutions, patient coverage and eligibility as well as stakeholder identification for acute and episodic (prevention) migraine treatments in Saudi Arabia and Egypt. They also wanted to gain understandings from key stakeholders on the reimbursement landscape and access potential for a new treatment expected to be launched for the treatment of migraine

Solution

In-depth secondary research was conducted to gather understanding on:

• Product Availability & reimbursement status in Egypt & KSA
• Market overview and migraine landscape
• Detailed analysis of affordability solutions in both markets

Identified KOLs and conducted primary research in Saudi Arabia on:

• Pricing and Reimbursement processes
• Treatment landscape
• Stakeholder perception on new therapy
• Stakeholder perception on product WTP

Results

• We enabled the client to attain valuable insights into the outlined markets,
• Identify key stakeholders and decision making processes
• Helped client gain clear insights into the disease burden, accessibility, unmet needs, and treatment protocols in the migraine therapy market
• Helped client gain an understanding of stakeholder perception and potential for a proposed product in the region